Shanghai-based drug developer Allist Pharmaceuticals has raised RMB1.2 billion ($171 million) in a Series A round of funding led by Shiyu Capital. Other participants include Loyal Valley Capital and Suzhou Industrial Park Bioventure Investment.
Established in 2004, the company focuses on treatments for tumours and diabetes. It has launched two drugs so far - one for stomach diseases and the other for high blood pressure. It has a further eight...
Legend Capital has absorbed lessons from its corporate sponsor to build a diversified investment business across the US dollar and renminbi spaces. It is now trying to take LP relations to a new level
Cerberus Capital Management has agreed to acquire the operating assets of bankrupt Australian equipment finance specialist Axsesstoday.
Sodexo Ventures, the venture capital arm of French food and facilities management services conglomerate Sodexo, has made its second investment in China, committing an undisclosed amount to technology-enabled catering service Meican.
Global Brain has led a $7.8 million round for Idein, a Japanese technology developer focused on systems for device-level data processing, also known as edge computing.